Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
By W. Al-Jamal, Kostas Kostarelos. Accounts of Chemical Research, 2011
636 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/b136341cadf15c3ba83e3aa2d3afbd4fa1b0ac51
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Molecular Biology
- S. Biswas
- Pranali P. Deshpande
- Vladimir Torchilin
- D. Richardson
- D. Kalinowski
- Phatsapong Yingchoncharoen
Citations in the corpus
- Current trends in the use of liposomes for tumor targeting (2013, background): “The multifunctional design of MSN systems offers next-generation nanocarriers combining features such as targetability of ligands and triggered responses that simulate molecular valves, when multicompartmentalized cargos are delivered to target cells [112,113].”